CD47 and neoplasm: As DCs appear to play a pivotal role in the cross-priming of antitumor T-cell response mediated by anti-CD47 mAb [28, 35], we investigated whether NI-1701-induced tumor cell phagocytosis by DCs could trigger antigen cross-presentation to T cells.